Perrigo Navigates Earnings Storm Weathering Change At Helm
This article was originally published in The Tan Sheet
The OTC private label giant promotes John Hendrickson from president to CEO after Joseph Papa resigns to take the same post at beleaguered specialty pharma Valeant Pharmaceutical International. A lower earnings forecast combined with the leadership change sent Perrigo's share price down 18.09%.
Register for our free email digests: